We are monitoring the impact of COVID-19 on North America IVF Market Get in touch with us for detailed analysis Know More
Share on

North America In-Vitro Fertilization Market Research Report – Segmented By Reagents & Media, Instruments, Technology, End Users & Country (The United States, Canada and Rest of North America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 259
Pages: 135

North America IVF Market Size (2022 to 2027)

The size of the North American In-vitro fertilization market is expected to worth USD 1.87 billion by 2027 from USD 0.88 billion in 2022, growing at a CAGR of 16.2% between 2022 to 2027.

The IVF (In Vitro Fertilization) market in North America is expected to be driven by an increase in the number of fertility clinics and infertility services and increased product launches due to government support. The key drivers predicted to drive the IVF market's development in the North America region include an increase in the median age of first-time motherhood, falling fertility rates, rising male infertility, rising alcohol and cigarette usage, newly opened fertility facilities, and reimbursement policies for infertility treatment and increased public awareness about infertility and treatment alternatives. In addition, the market for fertility therapy is expected to expand in health because of the large patient population, growing product launches, the presence of strong market players, and rising government support.

Improved progressive motility, a greater proportion of normal morphology, better fertilization rates, and higher euploidy and pregnancy rates result from healthier sperm. The better results related to these gadgets could drive up demand in the future. In addition, increased awareness of sophisticated in vitro fertilization (IVF) procedures, increased IVF success rates, and diseases caused by the delayed beginning of pregnancy have all boosted the demand for IVF techniques in this region. The key measures activating a woman's ovulatory system, extracting an ovum from her ovaries, and fertilizing the ovum with sperm in a laboratory liquid. IVF is one of the most often utilized procedures to help couples with infertility difficulties, a major driver driving the IVF services market. Cultural change, which includes factors such as an increase in the number of women in the workforce, an increase in the age at which women have their first child, a steady shift from rural to urban communities, and lower marriage rates, is one of the primary causes of reduced Total Fertility Rate (TFR). On the other hand, advances in IVF therapies have brought up new prospective opportunities and favorable outcomes from diverse procedures.

The growth of the North American IVF market is likely to be hampered by the high procedure costs of assisted reproductive technologies and problems connected with IVF and the associated socio-ethical considerations. In addition, the high cost and difficulties of IVF therapy and a lack of knowledge about IVF in some areas are challenging the growth of the North America In Vitro Fertilization market.

This research report on the North American IVF Market has been segmented and sub-segmented into the following categories:

By Reagents and Media:

  • Embryo Culture Media            
  • Cryopreservation Media          
  • Sperm Processing Media          
  • Ovum Processing Media   

By Instruments:

  • Imaging Systems
  • Sperm Separation Systems
  • Ovum Aspiration Pumps
  • Incubators
  • Micromanipulator Systems
  • Cryptosystem
  • Other Instruments (Gas Analyzers, Laser Systems, Accessories)

By Technology:

  • Intra-Cytoplasmic Sperm Injection (ICSI)
  • Pre-Implantation Genetic Diagnosis (PGD)
  • Frozen Embryo Transfer/Replacement (FET/FER)
  • Other Technologies

By End Users:

  • Fertility and Surgical Centers
  • Hospitals and Research Laboratories
  • Cryobanks

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, the North American IVF market is forecasted to account for a significant share in the global market during the forecast period. Because of the growing frequency of related diseases such as Polycystic Ovary Syndrome, the In Vitro Fertilization market in North America is projected to develop significantly (PCOS). In addition, the research market in the area is expected to be driven by a steady rise in the incidence of infertility in both sexes. The growth in male infertility is expected to boost IVF treatment adoption and, as a result, accelerate the in vitro fertilization market size in the future years. Aside from that, government-backed reimbursement regulations and public awareness campaigns assist the region's overall in vitro fertilization industry growth.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North American IVF Market profiled in this report are CooperSurgical, Inc. (U.S.), Vitrolife AB (Sweden), Cook Medical, Inc. (U.S.), Irvine Scientific (U.S.), Thermo Fisher Scientific, Inc. (U.S.), EMD Serono, Inc. (U.S.), Genea Limited (Australia), ESCO Micro Pte. Limited (Singapore), IVFtech ApS (Denmark), and The Baker Company, Inc. (U.S.)

RECENT MARKET HAPPENINGS:

February 2018: In-vitro fertilization-focused machine learning company Univfy has raised USD 6 million in Series funding. Univfy developed machine learning technology, which aims to reduce the financial burden on those affected by infertility.

  1. Introduction

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

  1. Research Methodology

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

  1. Overview

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                               

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

  1. Market Segmentation

                5.1 Introduction                                               

                5.2 Reagents and Media                                              

                                5.2.1 Introduction                           

                                5.2.2 Embryo Culture Media                       

                                5.2.3 Cryopreservation Media    5.2.2.1 Autologous Cell-Based Products

                                5.2.4 Sperm Processing Media   5.2.2.2 Allogeneic Cell-Based Products  

                                5.2.5 Ovum Processing Media                   

                5.3 Instruments                                               

                                5.3.1 Introduction                           

                                5.3.2 Imaging Systems                  

                                5.3.3 Sperm Separation Systems                              

                                5.3.4 Ovum Aspiration Pumps                   

                                5.3.5 Incubators                               

                                5.3.6 Micromanipulator Systems                              

                                5.3.7 Cryosystems                          

                                5.3.8 Other Instruments (Gas Analyzers, Laser Systems, Accessories)                     

                5.4 Technology                                 

                                5.3.1 Introduction                           

                                5.3.2 Intra-Cytoplasmic Sperm Injection (ICSI)                   

                                5.3.3 Pre-Implantation Genetic Diagnosis (PGD)                               

                                5.3.4 Frozen Embryo Transfer/Replacement (FET/FER)                  

                                5.3.5 Other Technologies                             

                5.5 End Users                                    

                                5.4.1 Introduction                           

                                5.4.2 Fertility and Surgical Centers                           

                                5.4.3 Hospitals and Research Laboratories                           

                                5.4.4 Cryobanks                               

  1. Geographical Analysis

                                6.1 Introduction                               

                                6.2 United States                            

                                6.3 Canada                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

  1. Market Leaders' Analysis

                8.1 CooperSurgical, Inc. (U.S.)                                   

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Cook Medical, Inc. (U.S.)                                      

                8.3 Irvine Scientific (U.S.)                                             

                8.4 Vitrolife AB (Sweden)                                            

                8.5 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.6 EMD Serono, Inc. (U.S.)                                        

                8.7 Genea Limited (Australia)                                    

                8.8 ESCO Micro Pte. Limited (Singapore)                                               

                8.9 IVFtech ApS (Denmark)                                        

                8.10 The Baker Company, Inc. (U.S.)                                       

  1. Competitive Landscape

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

  1. Expert Opinions

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

    Appendix                                                          

a) List of Tables

b) List of Figures

  1. North America In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  2. North America In-Vitro Fertilization Market, By Reagents and Media, From 2022 - 2027 (USD Million)
  3. North America Embryo Culture Media In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  4. North America Cryopreservation Media In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  5. North America Sperm Processing Media In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  6. North America Ovum Processing Media In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  7. North America In-Vitro Fertilization Market, By Instruments, From 2022 - 2027 (USD Million)
  8. North America Imaging Systems In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  9. North America Sperm Separation Systems In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  10. North America Ovum Aspiration Pumps In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Incubators In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  12. North America Micromanipulator Systems In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Cryosystems In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Other Instruments In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  15. North America In-Vitro Fertilization Market, By Technology, From 2022 - 2027 (USD Million)
  16. North America Intra-Cytoplasmic Sperm Injection In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  17. North America Pre-Implantation Genetic Diagnosis In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  18. North America Frozen Embryo Transfer/Replacement In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Other Technologies of In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  20. North America In-Vitro Fertilization Market, By End Users, From 2022 - 2027 (USD Million)
  21. North America Fertility and Surgical Centers In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  22. North America Hospitals and Research Laboratories In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  23. North America Cryobanks In-Vitro Fertilization Market, By Region, From 2022 - 2027 (USD Million)
  24. United States In-Vitro Fertilization Market, By Reagents and Media, From 2022 - 2027 (USD Million)
  25. United States In-Vitro Fertilization Market, By Instruments, From 2022 - 2027 (USD Million)
  26. United States In-Vitro Fertilization Market, By Technology, From 2022 - 2027 (USD Million)
  27. United States In-Vitro Fertilization Market, By End Users, From 2022 - 2027 (USD Million)
  28. Canada In-Vitro Fertilization Market, By Reagents and Media, From 2022 - 2027 (USD Million)
  29. Canada In-Vitro Fertilization Market, By Instruments, From 2022 - 2027 (USD Million)
  30. Canada In-Vitro Fertilization Market, By Technology, From 2022 - 2027 (USD Million)
  31. Canada In-Vitro Fertilization Market, By End Users, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample